Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
Fortune -

The blockbuster drug from Novo Nordisk has a list price of about $1,350 per month in the US.

Related Articles

Latest in News

More from Fortune | Diabetes Health Insurance heart disease Novo Nordisk Wegovy Weight Loss Health care